In a trial, selected patients with early non-small cell lung cancer did not benefit from mediastinal lymph node dissection (LND). Mediastinal LND resulted in longer surgeries, increased bleeding, and ...
New findings of an Alliance Foundation Trials study show combining immunotherapy and chemotherapy before surgery improves ...
The field of lung cancer research has increasingly turned its attention to the tumor immune microenvironment (TIME) in non-small cell lung cancer (NSCLC), ...
The Journal of Clinical Oncology podcast, hosted by Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO’s esteemed Journal of Clinical Oncology.
In a 2024 Journal of Thoracic Oncology review, Haiquan Chen, MD, PhD, of Fudan University Shanghai Cancer Center in China, and colleagues backed the use of selective lymph node dissection (LND) to ...
SAN FRANCISCO, September 29, 2025 — A new clinical trial report finds that stereotactic radiation therapy offers long-term survival outcomes comparable to surgery for patients with small, early-stage ...
Analysis of a large non-small cell lung cancer (NSCLC) patient cohort with stage IV M1a disease identified lymph node staging as having clinical significance and an impact on prognosis. Lung cancer is ...
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study We conducted a multicenter, open-label, ...
Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting demonstrating that stereotactic body ...
New findings of an Alliance Foundation Trials study show combining immunotherapy and chemotherapy before surgery improves ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results